Elite Pharmaceuticals Inc (ELTP): Shareholders' Equity
$98.88M
As of 2026-03-31
$104.83M
As of 2026-06-30
+50.6%
3-year compound annual growth
+43.7%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $98.88M | +84.8% | 2026-06-29, Balance as of period end |
| 2025-03-31 | $53.52M | -7.1% | 2026-06-29, Balance as of period end |
| 2024-03-31 | $57.58M | +98.8% | 2025-06-30, Balance as of period end |
| 2023-03-31 | $28.96M | +14.8% | 2024-07-01, Balance as of period end |
| 2022-03-31 | $25.22M | +56.2% | 2023-06-29, Balance as of period end |
| 2021-03-31 | $16.15M | +51.6% | 2022-06-29, Balance as of period end |
| 2020-03-31 | $10.66M | n/m | 2021-06-14, Balance as of period end |
| 2019-03-31 | -$2.51M | n/m | 2020-06-29, Balance as of period end |
| 2018-03-31 | $4.57M | -82.2% | 2019-06-21, Balance as of period end |
| 2017-03-31 | $25.66M | n/m | 2018-06-14, Balance as of period end |
| 2016-03-31 | -$33.12M | n/m | 2018-06-14, Balance as of period end |
| 2015-03-31 | -$34.73M | n/m | 2017-06-14, Balance as of period end |
| 2014-03-31 | -$81.20M | n/m | 2016-06-15, Balance as of period end |
| 2013-03-31 | -$8.67M | n/m | 2014-06-30, Balance as of period end |
| 2012-03-31 | -$14.98M | n/m | 2013-06-21, Balance as of period end |
| 2011-03-31 | -$17.87M | n/a | 2012-06-29, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $98.88M | +84.8% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $55.59M | -52.1% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$292.93M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $14.33M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | $44.75M | -43.6% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $1.34M | -88.2% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $64.63M | -77.6% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$438.17M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $502.64M | +25.1% |
Compare ELTP, MGNX, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗